Retatrutide

Triple GIP / GLP-1 / glucagon receptor agonist used in metabolic research.

Select size

Qty

Total

$219.00

Purity: ≥ 99%
Mol. weight: 4731.400 Da
Sequence: Modified triple-agonist hybrid
Storage: Lyophilized: -20 °C, light-protected. Reconstituted: 2–8 °C, use within 14 days.

About

Retatrutide is a synthetic triple agonist targeting GIP, GLP-1, and glucagon receptors. It is investigated in vitro for combined incretin and energy-expenditure pathway research.

Research-use only

Sold strictly for in-vitro laboratory research. Not for human or veterinary consumption, diagnostic, or therapeutic use. See our research-use terms.

Batch & COA

Recent batches

No batches uploaded yet — every shipped vial will include the corresponding COA, also searchable at /coa.